Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients
Authors:
- Carol B TorisCTCarol B Toris
- Carl B CamrasCCCarl B Camras
- Michael E YablonskiMYMichael E Yablonski
- 1 July 1999
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 128 (1) , 8-14
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Comparison of the Efficacy of Apraclonidine and Brimonidine as Aqueous Suppressants in HumansArchives of Ophthalmology (1950), 1998
- Brimonidine TartrateOphthalmology, 1997
- Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertensionSurvey of Ophthalmology, 1996
- A 90-Day Study of the Efficacy and Side Effects of 0.25% and 0.5% Apraclonidine vs 0.5% TimololArchives of Ophthalmology (1950), 1996
- Comparison of Apraclonidine and Timolol in Chronic Open-angle GlaucomaOphthalmology, 1993
- Effect of apraclonidine on blood-aqueous barrier permeability to plasma protein in manExperimental Eye Research, 1992
- Selective α2-Adrenerigc Agonists B-HT 920 and UK14304-18Archives of Ophthalmology (1950), 1991
- Apraclonidine and TimololArchives of Ophthalmology (1950), 1991
- Aqueous Flow is Reduced by the Alpha-adrenergic Agonist, Apraclonidine Hydrochloride (ALO 2145)Ophthalmology, 1988
- ApraclonidineArchives of Ophthalmology (1950), 1988